128563-23-5

Usage

Uses

Used in Pharmaceutical Industry:
(3S,7R,10R,11R)-10-[(2R,3R,4R,5R,6S)-4-Amino-3,5-dihydroxy-6-methyl-oxan-2-yl]oxy -3,11-diethyl-7 -methyl-1-azacyclotetradecan-2-one is used as a pharmaceutical compound for its potential therapeutic effects. The presence of the amine and sugar groups, along with the cyclical structure, may allow for interactions with biological targets, making it a candidate for drug development.
Used in Biochemistry Research:
In biochemistry, (3S,7R,10R,11R)-10-[(2R,3R,4R,5R,6S)-4-Amino-3,5-dihydroxy-6-methyl-oxan-2-yl]oxy -3,11-diethyl-7 -methyl-1-azacyclotetradecan-2-one can be utilized as a research tool to study the interactions between complex molecules and biological systems. Its unique structure may provide insights into molecular recognition and binding processes.
Used in Materials Science:
(3S,7R,10R,11R)-10-[(2R,3R,4R,5R,6S)-4-Amino-3,5-dihydroxy-6-methyl-oxan-2-yl]oxy -3,11-diethyl-7 -methyl-1-azacyclotetradecan-2-one may also find applications in materials science, where its functional groups and cyclical structure could be exploited to create new materials with specific properties. This could include the development of novel catalysts, sensors, or other advanced materials.

InChI:InChI=1/C24H46N2O5/c1-5-17-11-8-14-26-23(29)18(6-2)10-7-9-15(3)12-13-19(17)31-24-22(28)20(25)21(27)16(4)30-24/h15-22,24,27-28H,5-14,25H2,1-4H3,(H,26,29)/t15-,16-,17+,18+,19+,20+,21+,22+,24-/m0/s1

Upstream product

• 183854-52-6 (3R,3aR,6aS)-2-((R)-1-Phenyl-ethyl)-3-((4S,5S)-2,2,5-trimethyl-[1,3]dioxolan-4-yl)-tetrahydro-[1,3]dioxolo[4,5-d]isoxazol-5-one 
• 183854-66-2 Acetic acid (2R,3R,4R,5S,6S)-5-acetoxy-2-{(R)-1-[(R)-1-ethyl-4-((R)-2-ethyl-hex-5-enoylamino)-butyl]-4-methyl-pent-4-enyloxy}-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester 
• 183854-59-3 Acetic acid (3R,4R,5S,6S)-5-acetoxy-2-fluoro-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester 
• 200491-14-1 (3R,3aR,6aS)-3-((1S,2S)-1,2-Dihydroxy-propyl)-2-((R)-1-phenyl-ethyl)-tetrahydro-[1,3]dioxolo[4,5-d]isoxazol-5-one 
• 161646-95-3 (R)-2-Ethyl-hex-5-enoic acid [(4R,5R)-5-(tert-butyl-dimethyl-silanyloxy)-4-ethyl-8-methyl-non-8-enyl]-amide 
• 161646-94-2 (R)-2-Ethyl-hex-5-enoic acid ((4R,5R)-4-ethyl-5-hydroxy-8-methyl-non-8-enyl)-amide 
• 197388-97-9 Acetic acid (2R,3R,4R,5S,6S)-5-acetoxy-2-{(R)-1-[(R)-1-ethyl-4-((S)-2-ethyl-hex-5-enoylamino)-butyl]-4-methyl-pent-4-enyloxy}-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester 
• 197388-99-1 Acetic acid (3R,4R,5S,6S)-5-acetoxy-6-methyl-2-phenylsulfanyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester 
• 183854-69-5 Acetic acid (2R,3R,4R,5S,6S)-5-acetoxy-2-((Z)-(5R,6R,13R)-5,13-diethyl-9-methyl-14-oxo-azacyclotetradec-9-en-6-yloxy)-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester 
• 183854-57-1 Acetic acid (2S,3R,4R,5S,6S)-2,5-diacetoxy-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester 
• 197388-98-0 Acetic acid (2R,3R,4R,5S,6S)-5-acetoxy-2-methoxy-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester 
• 183854-63-9 (4R,5R)-5-(tert-Butyl-dimethyl-silanyloxy)-4-ethyl-8-methyl-non-8-enylamine 
• 161646-90-8 N-((4R,5R)-4-Ethyl-5-hydroxy-8-methyl-non-8-enyl)-4-methyl-benzenesulfonamide 
• 197388-77-5 (S)-2-Ethyl-hex-5-enoic acid [(4R,5R)-5-(tert-butyl-dimethyl-silanyloxy)-4-ethyl-8-methyl-non-8-enyl]-amide 

Relevant academic research and scientific papers

Applications of Zr-catalyzed carbomagnesation and Mo-catalyzed macrocyclic ring closing metathesis in asymmetric synthesis, enantioselective total synthesis of Sch 38516 (fluvirucin B1)

The first enantioselective total synthesis of antifungal agent Sch 38516, also known as fluvirucin B1, is described. The synthesis includes a convergent asymmetric preparation of amine 17 and acid 18, which are then united to afford diene 62. Metal-catalyzed transformations play a crucial role in the synthesis of the latter moiety. Of particular note are the diastereo- and enantioselective Zr-catalyzed alkylations, a tandem Ti- and Ni-catalyzed process that constitutes a hydrovinylation reaction, and a Ru-catalyzed alcohol oxidation to afford carboxylic acid 18. The requisite carbohydrate 38 is synthesized in a highly diastereo- and enantioselective fashion. Optical purity of the carbohydrate moiety arises from the use of the asymmetric dihydroxylation method of Sharpless; diastereochemical control is achieved through a selective dipolar [3 + 2] cycloaddition with a readily available amine serving as the chiral auxiliary. Union of the appropriately outfitted carbohydrate 71 and diene 62 through an efficient and diastereoselective glycosylation is followed by a remarkably efficient Mo-catalyzed macrocyclization that proceeds readily at room temperature.